The DNAAF1 gene helps build tiny moving cell hairs called cilia, which clear mucus from the airways and support sperm movement. The protein made by this gene helps your cells assemble the motor parts that let cilia beat. If the DNAAF1 gene does not work, cilia may not move well, which can cause primary ciliary dyskinesia with a long lasting wet cough, sinus and ear problems, repeated chest infections, fertility problems, and sometimes organs arranged differently before birth.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes carry the information needed to produce proteins, the working parts of cells. Others mainly help determine when certain processes take place, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. More in depth information on this topic is available in the LearnHub.
Overview
DNAAF1Gene function
What if the gene works
Your cells rely on the DNAAF1 gene to help assemble motor proteins needed for moving cilia, the tiny hairlike structures on some cells. This supports mucus clearance in the airways and normal sperm movement.
Risk
What if the gene does not work
More disruptive variants in the DNAAF1 gene can cause primary ciliary dyskinesia, often leading to ongoing sinus and lung problems. Some people also have organ placement differences, and fertility effects can vary with how much cilia movement is reduced.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the DNAAF1 gene, no treatment or drug choice tied specifically to this gene is currently established. The DNAAF1 gene is being studied in primary ciliary dyskinesia research to better understand cilia function, but this has not yet changed routine treatment.
Conditions associated with DNAAF1
Gene function
What if the gene works
Tiny moving hairs on certain cells help clear airways, move fluid, and support fertility. The DNAAF1 gene helps build the motor parts these hairs need to beat in a smooth, coordinated way. Understanding how the DNAAF1 gene works in motile cilia makes its everyday role in the body easier to picture.
Inside cells, the DNAAF1 gene helps assemble dynein (a motor protein) for motile cilia, the tiny moving hairs on some cells. This preparation happens before those motor parts are sent to the cilia.
By helping build these motor parts, the DNAAF1 gene supports the smooth, repeated beating of cilia. That motion helps move mucus, fluid, and reproductive cells where they need to go.
The DNAAF1 gene works with other cilia building proteins to organize and ready dynein parts. This makes the final cilia structure better able to move in a coordinated way.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help make up normal human diversity, such as variations in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can more substantially change how a gene functions and may contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DNAAF1 gene can make its protein unstable, unusually short, or unable to help build the tiny motor parts that let cilia move. This helps explain how DNAAF1 gene variants affect cilia movement: some changes leave a little activity in place, while more disruptive variants can remove most or all function. When that happens, cilia may beat weakly or not in a coordinated way. In people with primary ciliary dyskinesia, less remaining function can be linked to earlier or more noticeable features.
How variants are linked to conditions
Pathogenic variants in the DNAAF1 gene cause a form of primary ciliary dyskinesia, so the clearest DNAAF1 gene variants linked to conditions are in this inherited condition. People with this diagnosis often have ongoing chest and sinus infections, trouble clearing mucus, and sometimes differences in organ placement such as situs inversus, and some may also have reduced fertility.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are commonly found in the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, particularly when several genes and environmental factors contribute. In other cases, though, a single well-characterized variant in a specific gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For DNAAF1, risk is mainly shaped by genetics rather than lifestyle. A child usually develops the related cilia condition only if they inherit a harmful DNAAF1 change from both parents, so family history and parents being blood relatives can raise the chance, while there is not enough evidence that diet, exercise, or other everyday habits change this genetic risk.
Inheritance of DNAAF1 variants
DNAAF1-related conditions are inherited in an autosomal recessive pattern, which means a person usually needs to inherit two altered copies of the DNAAF1 gene, one from each parent. Parents who each carry one DNAAF1 variant are often healthy themselves but have a 25% chance with each pregnancy of having a child with a DNAAF1-related condition. In families asking how DNAAF1 variants are inherited, this also means each child has a 50% chance of being a carrier and a 25% chance of inheriting no altered copy.
What does my DNAAF1 result mean for my family?
For families with a disease-causing change in the DNAAF1 gene, this usually means a recessive inherited condition linked to primary ciliary dyskinesia, a condition that affects how tiny hair-like structures move in the airways and other parts of the body. Brothers and sisters may also be affected or may be healthy carriers, and parents are often carriers as well. Children of someone with DNAAF1-related primary ciliary dyskinesia will usually be carriers unless the other parent also carries a disease-causing DNAAF1 change.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for DNAAF1 variants usually uses a blood or saliva sample, and the lab reads the DNAAF1 gene to look for changes in its DNA code. Testing may be part of a panel for primary ciliary dyskinesia or broader sequencing, and results may show a disease-causing variant, no relevant variant, or a change that needs more interpretation.
When should I consider getting a genetic test?
Genetic testing for the DNAAF1 gene may be worth considering if someone has signs of a rare inherited condition called primary ciliary dyskinesia, with a long history of daily wet cough, repeated sinus or chest infections, or organs that developed in unusual positions. It can also help when this condition runs in the family or when infertility is part of the picture.
A genetic result is only one part of your health story
A genetic finding can provide meaningful insight, but how much it reveals depends on the condition and the kind of variant involved. Lifestyle, environment, age, medical history, and other influences shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information adds context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic finding may offer a clear answer. In areas such as medication response, genetic results can help place individual experiences in perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment may work well for one person, have less effect in another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that looks at how genetic differences shape responses to medications. It examines relationships between genes and drugs to help explain why treatment effects can vary from one person to another. With many medicines, genes can affect how strongly a drug works or how the body handles it. This information can help guide more informed and individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the DNAAF1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about medicines, side effects, or your health are best discussed with your doctor.
History
The DNAAF1 gene entered the medical literature after researchers studying cilia in animal models identified a related gene called LRRC50. In 2010, human studies connected variants in this gene with primary ciliary dyskinesia, helping explain why some families had long standing patterns of chronic chest infections, sinus problems, and laterality differences. As medical science evolved, so did understanding of this gene, and LRRC50 became known as the DNAAF1 gene to reflect its role more clearly. This work helped expand the list of genes involved in motile cilia conditions. It also marked an important step in moving from symptom based descriptions to gene based diagnosis in this area of medicine.